Category: biologic
Aliases: Emgality, anti-CGRP ligand mAb
Humanised IgG4 mAb binding CGRP ligand with high affinity → blocks CGRP engagement of the canonical trigeminovascular receptor. Only CGRP mAb with an FDA indication for episodic cluster headache. Onset within the first month; well tolerated with minimal systemic side effects.
SC: 648h